FIRM FIXED PRICENO SET ASIDE USED.
XLCARE PHARMACEUTICALS INC - AWARD TO XLCARE PHARMACEUTICALS FOR METHOCARBAMOL TABLETS FOR THE BASE YEAR WITH FOUR ONE-YEAR OPTIONS.
PIID: 36E79724D0018Solicitation ID: 36E79724R0005
Signed Date: Feb 3, 2026Effective Date: Mar 23, 2024
Key Details
Description
AWARD TO XLCARE PHARMACEUTICALS FOR METHOCARBAMOL TABLETS FOR THE BASE YEAR WITH FOUR ONE-YEAR OPTIONS.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.